Broadway

Broadway: Counter has been making new 52-week lows after its latest 2Q13 results on 30 Jul, where net profit tanked to near breakeven at $0.2m (-97%) vs $5.8m in prior period, while revenue dipped to $158.6m (-8.5%) on continued weakness in HDD shipments, partially mitigated by growth in precision component sales. Gross margins shrank to 2.3 ppt to 7.9% due to sub-optimal capacity utilisation. No interim dividends declared compared to 1¢ for 1H12.